Hashiramoto M, Kadowaki T, Clark A E, Muraoka A, Momomura K, Sakura H, Tobe K, Akanuma Y, Yazaki Y, Holman G D
Second Department of Internal Medicine, Kobe University School of Medicine, Japan.
J Biol Chem. 1992 Sep 5;267(25):17502-7.
The structure-function relationship of the HepG2/erythrocyte-type glucose transporter (GLUT1) has been studied by in vitro site-directed mutagenesis. Chinese hamster ovary clones in which glucose transporters were transfected were shown by Western blotting with a GLUT1 anti-COOH-terminal peptide antibody to have expression levels of Gln282----Leu, Asn288----Ile, and Asn317----Ile mutations that were comparable with the wild type. All three mutant GLUT1 clones had high 2-deoxy-D-glucose transport activity compared with a nontransfected clone, suggesting that these residues are not absolutely required for the transport function. We have examined the possibility that the inner and outer portions of the transport pathway are structurally separate by measuring the interaction of the mutant transporters with the inside site-specific ligand cytochalasin B and the outside site-specific ligand 2-N-4-(1-azi-2,2,2-trifluoroethyl)benzoyl-1,3-bis(D-mannos-4 -yloxy)-2- propylamine (ATB-BMPA). All three mutant GLUT1 clones showed high levels of cytochalasin B labeling, and the N288I and N317I mutants showed high levels of ATB-BMPA labeling. In contrast to the transport and cytochalasin B labeling results, the transmembrane helix 7 Gln282----Leu mutant was labeled by ATB-BMPA to a level that was only 5% of the level observed in the wild type. We have confirmed that this mutant was defective in the outer site by comparing the inhibition of wild-type and mutant 2-deoxy-D-glucose transport by the outside site-specific ligand 4,6-O-ethylidene-D-glucose. 4,6-O-Ethylidene-D-glucose inhibited wild-type transport with a Ki of approximately 12 mM, but this was increased to greater than 120 mM in the Gln282----Leu mutant. Thus, of the 3 residues mutated in this study, only glutamine 282 substitution causes a major perturbation in function, and this is a specific and striking reduction in the affinity for the outside site-specific ligands ATB-BMPA and 4,6-O-ethylidene-D-glucose.
通过体外定点诱变研究了HepG2/红细胞型葡萄糖转运体(GLUT1)的结构-功能关系。用GLUT1抗羧基末端肽抗体进行蛋白质免疫印迹分析显示,转染了葡萄糖转运体的中国仓鼠卵巢克隆中,Gln282→Leu、Asn288→Ile和Asn317→Ile突变体的表达水平与野生型相当。与未转染的克隆相比,所有三个突变型GLUT1克隆都具有较高的2-脱氧-D-葡萄糖转运活性,这表明这些残基对于转运功能并非绝对必需。我们通过测量突变型转运体与内部位点特异性配体细胞松弛素B以及外部位点特异性配体2-N-4-(1-叠氮基-2,2,2-三氟乙基)苯甲酰基-1,3-双(D-甘露糖-4-氧基)-2-丙胺(ATB-BMPA)的相互作用,研究了转运途径的内部和外部部分在结构上是否分离的可能性。所有三个突变型GLUT1克隆都显示出高水平的细胞松弛素B标记,并且N288I和N317I突变体显示出高水平的ATB-BMPA标记。与转运和细胞松弛素B标记结果相反,跨膜螺旋7的Gln282→Leu突变体被ATB-BMPA标记的水平仅为野生型观察水平的5%。通过比较外部位点特异性配体4,6-O-亚乙基-D-葡萄糖对野生型和突变型2-脱氧-D-葡萄糖转运的抑制作用,我们证实了该突变体在外部位点存在缺陷。4,6-O-亚乙基-D-葡萄糖抑制野生型转运的Ki约为12 mM,但在Gln282→Leu突变体中增加到大于120 mM。因此,在本研究中突变的3个残基中,只有谷氨酰胺282的取代导致功能上的主要扰动,这是对外部位点特异性配体ATB-BMPA和4,6-O-亚乙基-D-葡萄糖亲和力的特异性显著降低。